Valence ロゴ
人気
ログイン
Loading data for AGMB — first visit, this takes a few seconds.

ウォッチリストに追加

AgomAb Therapeutics NV

NasdaqGS: AGMB · リアルタイム株価 · USD
13.17
-0.67 (-4.84%)
終値時点： Aug 28, 2026, 3:59 PM
13.17
+0.00%
時間外: 7:30 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

AgomAb Therapeutics NV（AGMB）の株価・分析・データ

-4.84%
買気配10.01
時価総額648.6M
売上高（TTM）n/a
純利益（TTM）-81.6M
n/a
-1.58
n/a
-6.36
PBR（TTM）4.99
PSR（TTM）n/a
決算発表日n/a
売気配16.81
出来高252,919
平均出来高（20日）108,512
始値13.84
前日終値13.84
当日レンジ12.84 - 14.20
52週レンジ8.75 - 17.82
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

AGMBについて

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases in the United States. The company's product pipeline includes Ontunisertib (AGMB-129), an oral gastrointestinal-restricted small molecule inhibitor of ALK5 or TGFßR1 for the treatment of Fibrostenosing Crohn's disease, which is in Phase 2a clinical trials; and AGMB-447, an inhaled small molecule i...

[続きを読む]
業種 Biotechnology
セクター Healthcare
IPO日 Feb 6, 2026
従業員数 62
上場取引所 NasdaqGS
ティッカー AGMB
ウェブサイト https://www.agomab.com
企業情報の全文

業績

2025年のAgomAb Therapeutics NVの売上高は0で、前年の0からundefined%の増加でした。 利益は-62.55Mで、35.19%の増加でした。

財務諸表
news image

1か月前 · Insider Monkey

Is AgomAB Therapeutics NV (AGMB) Stock a Biotech Opportunity With Targeted Tissue Therapy Potential?

We recently compiled a list of the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now. AgomAB Therapeutics NV (NASDAQ:AGMB) is one of the best up and coming stocks on our list. TheFly reported on J...

news image

2か月前 · MT Newswires

Agomab Therapeutics Shares NOV-ERA Phase 2b Study Design With Ontunisertib in Fibrostenosing Crohn's Disease

Agomab Therapeutics (AGMB) said late Tuesday it has designed its upcoming phase 2b NOV-ERA study wit

news image

4か月前 · Insider Monkey

AgomAb Therapeutics (AGMB) Wins U.S. Patent for AGMB-447

AgomAb Therapeutics NV (NASDAQ:AGMB) is one of the 7 Best Strong Buy European Stocks to Invest In. On March 26, 2026, AgomAb Therapeutics NV (NASDAQ:AGMB) announced that the U.S. Patent and Trademark ...

news image

6か月前 · MT Newswires

European Equities Traded in the US as American Depositary Receipts Higher Wednesday

European equities traded in the US as American depositary receipts were rising on Wednesday morning,

news image

6か月前 · TipRanks

Agomab indicated to open at $15.50, IPO priced at $16

Agomab (AGMB) priced 12.5M shares at $16.00, inside the $15.00-$17.00 target range. JPMorgan, Morgan Stanley, Leerink and Kempen are acting as joint book running managers for the offering. Agomab is a...